http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019075403-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c72d118f5664072de841f9c5c34b9d99 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57419 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06V20-69 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2018-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c778830c1b6de4e7a4f10d0988ae862a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_807819a67e9caf96688ce7ae88a8c592 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10d49c59225ef4a39cbf84a387997d2f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7743e59453454c30085174eb669c11e |
| publicationDate | 2019-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2019075403-A1 |
| titleOfInvention | PROGNOSTIC CHARACTERIZATION OF BIOLOGICAL SAMPLE |
| abstract | The present invention relates to the prognostic characterization of biological samples. By way of example, the invention relates to systems and methods for performing a prognostic characterization of a biological sample from a cancer patient. The method comprises measuring the marker characteristics of individual markers in a panel of predefined markers that include at least a first marker specifically measured in tumor cells in the epithelial region and a second different marker measured specifically in non-tumor cells in the region. stromale where the marker characteristics of the first and second markers allow, individually or in combination, to clinically predict a risk of recurrence of a cancer. A biological prognostic signature is also developed based on the measured marker characteristics. |
| priorityDate | 2017-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 282.